Jason A. Chesney, MD, PhD of the James Graham Brown Cancer Center discusses the most exciting and interesting presentations coming out of ASCO 2017, which include three oral presentations, focusing on the efficacy of FDA-approved combination regiments in melanoma patients who have brain metastases. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Efficacy of FDA-Approved Combination Regimens in Melanoma Patients with Brain Metastases
